Sonja M.
- Country
- Germany
- Department
- Inflammations- und Immundermatologie Charité (IIDC)
Research Overview
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- Efficacy and Safety Evaluation of SAR441566 in Adults with Moderate to Severe Plaque Psoriasis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Comparative Efficacy of Risankizumab Versus Deucravacitinib in Adult Patients with Moderate Plaque Psoriasis Eligible for Systemic Therapy
Data & Insights
Has run more than one trial at 191 of 394 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in the study of Hidradenitis Suppurativa, a chronic inflammatory skin condition that significantly impacts patient quality of life.
- Chronic Inflammatory Skin Disorders
- Long-term Disease Management
- Novel Therapeutic Approaches
The investigator's work centers on evaluating innovative treatment options and understanding long-term therapeutic outcomes in dermatological conditions.
Therapeutic Innovation
Research focus includes investigating selective treatment approaches for chronic skin conditions, with particular emphasis on novel therapeutic agents.
- Treatment Safety Evaluation
- Extended Duration Therapy
- Clinical Efficacy Assessment
The investigator explores the long-term therapeutic potential of emerging treatments in dermatology.
Clinical Research
Expertise in conducting long-term extension studies to evaluate the sustained effectiveness and safety of dermatological treatments.
- Safety Monitoring
- Treatment Outcomes
- Patient Response Assessment
The investigator's research emphasizes comprehensive evaluation of therapeutic interventions in chronic skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.